Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option.

Ren, Yi; Miao, Jia-Meng; Wang, Yuan-Yuan; Fan, Zheng; Kong, Xian-Bin; Yang, Long; Cheng, Gong

Ren, Yi; Miao, Jia-Meng; Wang, Yuan-Yuan; Fan, Zheng; Kong, Xian-Bin; Yang, Long; Cheng, Gong.

Afiliación

Ren Y; College of Traditional Chinese medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Miao JM; College of Traditional Chinese medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Wang YY; Research Center for Infectious Diseases, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Fan Z; School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Kong XB; Department of Critical Medicine, The First Affiliated Hospital of Suzhou University, Suzhou, China.
Yang L; College of Traditional Chinese medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Cheng G; Research Center for Infectious Diseases, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Front Immunol ; 13: 961796, 2022.

Article en En | MEDLINE | ID: mdl-35911673

Asunto(s)

Neoplasias Colorrectales; Viroterapia Oncolítica; Virus Oncolíticos; Humanos; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Inmunoterapia/métodos; Inestabilidad de Microsatélites; Viroterapia Oncolítica/métodos; Virus Oncolíticos/genética; Microambiente Tumoral

Palabras clave

colorectal cancer; immune checkpoint inhibitor; immunotherapy; oncolytic viruses; tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Virus Oncolíticos / Viroterapia Oncolítica Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google